Childhood cancer is the most common cause of death from disease for children in the United States and Project:EveryChild is working to change that. Developed in partnership with the Children’s Oncology Group (COG) and funded, in part, by Rally Foundation, Project:EveryChild is focused on finding better cures for every type of childhood cancer—regardless of how
Dr. Gregory Friedman’s Immunotherapy Research for Recurrent Brain Tumors Shows Promising Preliminary Results
As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the
At just five years old, Rally Kid Charley’s favorite thing in the world is cuddling. “Charley just loves to love,” gushes her mom. “If she could hug, kiss, and cuddle all day long, she would!” Charley’s lovable nature and happy disposition are contagious—and extraordinary when considering what she’s been through at such a young age.